Related references
Note: Only part of the references are listed.AACE Comprehensive Diabetes Management Algorithm 2013
Alan Garber et al.
Endocrine Practice (2015)
Pioglitazone and bladder cancer: a propensity score matched cohort study
Li Wei et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern
C. J. Currie et al.
DIABETES OBESITY & METABOLISM (2012)
Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
A. Neumann et al.
DIABETOLOGIA (2012)
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
Laurent Azoulay et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design
David Preiss et al.
AMERICAN HEART JOURNAL (2011)
Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
Assiamira Ferrara et al.
DIABETES CARE (2011)
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone Interim report of a longitudinal cohort study
James D. Lewis et al.
DIABETES CARE (2011)
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Sreenivasa Rao Kondapally Seshasai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Diabetes and Cancer: A Consensus Report
Edward Giovannucci et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
R. E. Aubert et al.
DIABETES OBESITY & METABOLISM (2010)
Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction.
Robert W. Yeh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Peroxisome Proliferator-Activated Receptor-γ Contributes to the Inhibitory Effects of Embelin on Colon Carcinogenesis
Yun Dai et al.
CANCER RESEARCH (2009)
Declines in Acute Myocardial Infarction After Smoke-Free Laws and Individual Risk Attributable to Secondhand Smoke
James M. Lightwood et al.
CIRCULATION (2009)
An algorithm to identify incident myocardial infarction using Medicaid data
Neesha N. Choma et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
The Risk of Fractures Associated with Thiazolidinediones: A Self-controlled Case-Series Study
Ian J. Douglas et al.
PLOS MEDICINE (2009)
Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data
Christianne L. Rournie et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Effects of thiazolidinediones on bone loss and fracture
Catherine E. Murphy et al.
ANNALS OF PHARMACOTHERAPY (2007)
A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetest
Charles M. Gerrits et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia
Mark A. Deeg et al.
DIABETES CARE (2007)
Safety issues and prospects for future generations of PPAR modulators
Anne Rubenstrunk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Prospective study of diabetes and risk of hip fracture - The Nurses' Health Study
Mohsen Janghorbani et al.
DIABETES CARE (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies
R Huxley et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study.
II de Liefde et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia
RB Goldberg et al.
DIABETES CARE (2005)
Sketetal involvement in patients with diabetes mettitus
V Carnevale et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2004)
Marginal structural models as a tool for standardization
T Sato et al.
EPIDEMIOLOGY (2003)
Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women
KK Nicodemus et al.
DIABETES CARE (2001)
Older women with diabetes have an increased risk of fracture: A prospective study
AV Schwartz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Marginal structural models and causal inference in epidemiology
JM Robins et al.
EPIDEMIOLOGY (2000)
Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men
MA Hernan et al.
EPIDEMIOLOGY (2000)
Share Paper
